NC IDEA's Spring 2011 grants cycle opens on Monday, February 14th (applications will be accepted through 3/11). On Tuesday, February 15th, the organization will host an informational webinar aimed at giving potential grant applicants an overview of the grant process and eligibility criteria. Join NC IDEA officials as they discuss how to apply for a grant, what they look for in an application and what types of companies are eligible for funding.
To learn more and to register, go to:
www.ncidea.org/content/spring+2011+info+session/13511
Thursday, February 10, 2011
Subscribe to:
Posts (Atom)
Live Feeds Disclaimer
The live feeds below are provided direct from the source, including public and private sector sources such as the FDA, Medical Product Manufacturing News, BioSpace, and Twitter Feeds.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
MedCity News » North Carolina
- First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
- How UNC Health Saved Over $5M On Annual Nurse Turnover Costs
- How Genome Sequencing Can Broaden the Scope of Newborn Screening
- While Auto vs. Allo Cell Therapy Debate Continues, VCs Look for ‘Next Shiny Thing’
- Precision Bio Offloads Lead Cell Therapy Program in Pivot to In Vivo Gene Editing
FDA's Center for Devices and Radiological Health
Error loading feed.
Medical Product Manufacturing News
Error loading feed.
BioSpace.com Featured News and Stories
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
BioSpace.com Career News
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
NC Medical - Twitter Search
Error loading feed.
Biomedical Engineering - Twitter Search
Error loading feed.
Medical Device - Twitter Search
Error loading feed.
Pharmaceutical - Twitter Search
Error loading feed.
Biologics - Twitter Search
Error loading feed.
FDA Drug Info - Twitter Feed
Error loading feed.
FDA Recalls - Twitter Feed
Error loading feed.
FDA Women's Health - Twitter Feed
FasterCures Twitter Feed
Error loading feed.